Review The SDS Document
DOWNLOADProduct Details
Formula
C22H26ClN7O2S
MW
488.02
Purity
>97%
Solubility (DMSO Mg/MI)
90
Mode Of Action
inhibitor
Drug Status
Approved
Target Name
Tyrosine-protein kinase Srms
Research Area
CANCER
Research Area Sub Group
Anticancer
Pharmacology
ENZYMES
Pharmacology Area Sub Group
Kinase
![Dasatinib [STAGING] Key Organics](https://staging.keyorganics.net/app/uploads/2026/01/Key-Organics-40th-logo-strip-1.png)
